Suchergebnisse - "Tilg, Herbert"

PubPharm (632)

1

Clearance of gut mucosal SARS-CoV-2 antigens and post-acute COVID-19 after two years in patients with inflammatory bowel disease

enthalten in: Gastroenterology | 2024

von Zollner, A. | Koch, R. | Jukic, A. | +8

2

Innate Immunity and MASLD

enthalten in: Biomolecules | 2024

von Meyer, M. | Schwärzler, J. | Jukic, A. | +1

3

Intravenous iron-induced hypophosphatemia and kidney stone disease

enthalten in: Bone reports | 2024

von Panzer, M. | Meindl, E. | Schaefer, B. | +14

4

Ferritin-a promising biomarker in MASLD

enthalten in: Gut | 2024

von Zoller, H. | Tilg, H.

5

Relationship between Helicobacter pylori infection and risk of metabolic dysfunction-associated steatotic liver disease : An updated meta-analysis

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Mantovani, A. | Lando, M. | Borella, N. | +8

6

Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature

enthalten in: Journal of hepatology | 2024

von Lonardo, A. | Bril, F. | Caldwell, S. | +12

7

Penetrance, cancer incidence and survival in HFE haemochromatosis-A population-based cohort study

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Schaefer, B. | Pammer, L. | Pfeifer, B. | +10

8

The pathophysiology of MASLD : an immunometabolic perspective

enthalten in: Expert review of clinical immunology | 2024

von Schwärzler, J. | Grabherr, F. | Grander, C. | +2

9

MASLD : a systemic metabolic disorder with cardiovascular and malignant complications

enthalten in: Gut | 2024

von Targher, G. | Byrne, C. | Tilg, H.

10

Thyroid hormone receptor-beta agonists : new MASLD therapies on the horizon

enthalten in: Gut | 2024

von Byrne, C. | Targher, G. | Tilg, H.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[64]